CN107129962A - A kind of primary culture method of Hirudo japonica salivary gland cell - Google Patents
A kind of primary culture method of Hirudo japonica salivary gland cell Download PDFInfo
- Publication number
- CN107129962A CN107129962A CN201710354224.6A CN201710354224A CN107129962A CN 107129962 A CN107129962 A CN 107129962A CN 201710354224 A CN201710354224 A CN 201710354224A CN 107129962 A CN107129962 A CN 107129962A
- Authority
- CN
- China
- Prior art keywords
- japanese
- leech
- salivary gland
- pbs buffer
- primary culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003079 salivary gland Anatomy 0.000 title claims abstract description 37
- 241000237903 Hirudo Species 0.000 title claims abstract description 17
- 238000012136 culture method Methods 0.000 title claims abstract description 13
- 244000184734 Pyrus japonica Species 0.000 title 1
- 241000545744 Hirudinea Species 0.000 claims abstract description 54
- 210000001519 tissue Anatomy 0.000 claims abstract description 23
- 241000238631 Hexapoda Species 0.000 claims abstract description 8
- 230000003068 static effect Effects 0.000 claims abstract description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 21
- 239000000872 buffer Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 13
- 229960005322 streptomycin Drugs 0.000 claims description 13
- 229930182555 Penicillin Natural products 0.000 claims description 12
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 229940049954 penicillin Drugs 0.000 claims description 12
- 238000012546 transfer Methods 0.000 claims description 12
- 238000011081 inoculation Methods 0.000 claims description 11
- 229930183010 Amphotericin Natural products 0.000 claims description 9
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 claims description 9
- 229940009444 amphotericin Drugs 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 239000006143 cell culture medium Substances 0.000 claims description 7
- 239000012286 potassium permanganate Substances 0.000 claims description 6
- 230000028327 secretion Effects 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 4
- 210000002615 epidermis Anatomy 0.000 claims description 4
- 210000003300 oropharynx Anatomy 0.000 claims description 4
- 210000003491 skin Anatomy 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 abstract description 18
- 102000007625 Hirudins Human genes 0.000 abstract description 16
- 108010007267 Hirudins Proteins 0.000 abstract description 16
- 229940006607 hirudin Drugs 0.000 abstract description 16
- 238000004113 cell culture Methods 0.000 abstract description 11
- 238000011161 development Methods 0.000 abstract description 5
- 238000012360 testing method Methods 0.000 abstract description 5
- 238000000338 in vitro Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000012930 cell culture fluid Substances 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 description 16
- 239000002609 medium Substances 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 5
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 4
- 229960003942 amphotericin b Drugs 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 241000146385 Hirudo nipponia Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000002429 anti-coagulating effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 230000014508 negative regulation of coagulation Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000012984 antibiotic solution Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/30—Rearing or breeding invertebrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Microbiology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明属于生物工程技术领域,公开了一种日本医蛭唾液腺细胞的原代培养方法,将剪碎后的组织块接种于25cm2的细胞封闭培养瓶中,加入5mL SFX‑INSCET昆虫细胞培养液,置于生化培养箱中29℃静止培养。本发明将大大提高天然水蛭素的产量;极少量的野生日本医蛭唾液腺细胞进行体外细胞培养后就能得到大量的唾液腺细胞,分离提取出大量天然水蛭素,有利于野生日本医蛭种群的保护,达到既深度开发利用又大力保护动物种质资源的目标。本发明快速、有效、重复性强,是对蛭类细胞培养的完善,为蛭类细胞原代培养的研究提供可靠的试验数据与基础。
The invention belongs to the technical field of bioengineering, and discloses a primary culture method of Japanese hirudo salivary gland cells, inoculating the shredded tissue pieces in a 25cm closed cell culture bottle, adding 5mL SFX- INSCET insect cell culture fluid , placed in a biochemical incubator at 29°C for static culture. The present invention will greatly increase the output of natural hirudin; a large amount of salivary gland cells can be obtained after a very small amount of wild Japanese leech salivary gland cells are cultured in vitro, and a large amount of natural hirudin can be separated and extracted, which is beneficial to the protection of wild Japanese leech populations , to achieve the goal of both in-depth development and utilization and vigorous protection of animal germplasm resources. The invention is fast, effective and highly reproducible, perfects the culture of leech cells, and provides reliable test data and basis for the research on the primary culture of leech cells.
Description
技术领域technical field
本发明属于生物工程技术领域,尤其涉及一种日本医蛭唾液腺细胞的原代培养方法。The invention belongs to the technical field of bioengineering, and in particular relates to a method for primary culture of Japanese hirudo salivary gland cells.
背景技术Background technique
随着生命科学的迅速发展,不论对于整个生物工程技术,还是其中之一的生物克隆技术来说,细胞培养都是一个必不可少的过程,并推动着细胞生物学、分子生物学、生物化学等领域的发展。日本医蛭(Hirudo nipponia)属环节动物门,有环带亚门,蛭纲,无吻蛭目,医蛭科,医蛭属。据统计,分布在全世界的蛭类动物共有600多种,分布在我国的也有近100种。它们在江河、湿润的陆地以及田间生活,有的以取食鱼、蛙、水鸟及牛、马、人这样一些哺乳动物的血液为生,也有的靠取食蚯蚓、虾、螺、蚌之类的无脊椎动物的体液、组织以至整个身体而得以生存。以吸食哺乳动物血液为生,唾液腺分泌物中含有水蛭素等多种生物活性物质并且在医药上具有广阔应用前景的蛭类动物在国际上被统称为医学蛭类。研究发现,医学蛭类唾液腺分泌物中含有多种活性物质:水蛭素、水蛭透明质酸酶、安替斯塔辛、麻醉剂、血管扩张剂、前列腺素等。而日本医蛭作为天然水蛭素的重要来源之一,具有降血脂、保护心脑血管、抗凝血和抗肿瘤等功效,具有“软黄金”之称,更是具有重要的研究意义。目前国内国际上获取水蛭素的方法主要有两种,一种是直接从医蛭的唾液腺部位分离提取出天然水蛭素或者用精氨酸等刺激医蛭使其分泌唾液腺分泌,再使用特殊装置收集唾液,通过这种方法得到的天然水蛭素产量极小,耗费成本较高;另一种是通过基因工程的方法合成重组水蛭素,虽然在临床上与天然水蛭素的差异并不大,但是抗凝活性低,抗凝血作用的特异性会受到重组水蛭素浓度的影响,纯度高抗凝血作用也相应较高,因此,临床上对天然水蛭素需求很大。With the rapid development of life sciences, cell culture is an essential process for both the entire bioengineering technology and one of the biological cloning technologies, and promotes the development of cell biology, molecular biology, biochemistry development in other fields. Japanese medical leeches (Hirudo nipponia) belong to the phylum Annelids, which include the subphylum Annulus, class Hirudo, order Hirudo nipponia, family Hirudo, and genus Hirudo. According to statistics, there are more than 600 species of leeches distributed all over the world, and nearly 100 species are distributed in my country. They live in rivers, wet land, and fields. Some live by feeding on the blood of mammals such as fish, frogs, water birds, cattle, horses, and humans, and some feed on earthworms, shrimps, snails, and mussels. The body fluids, tissues and even the whole body of invertebrates can survive. The leech animals that suck the blood of mammals for a living, the salivary gland secretions contain hirudin and other biologically active substances, and have broad application prospects in medicine are collectively called medical leeches in the world. Studies have found that medical leech salivary gland secretions contain a variety of active substances: hirudin, leech hyaluronidase, antistacin, anesthetics, vasodilators, prostaglandins, etc. As one of the important sources of natural hirudin, Japanese medicine leech has the effects of lowering blood fat, protecting cardiovascular and cerebrovascular, anticoagulant and antitumor, and is known as "soft gold" and has important research significance. At present, there are two main ways to obtain hirudin at home and abroad. One is to directly separate and extract natural hirudin from the salivary glands of leeches, or stimulate the leeches to secrete salivary glands with arginine, and then use special equipment to collect them. Saliva, the natural hirudin obtained by this method has a very small yield and high cost; the other is to synthesize recombinant hirudin by genetic engineering. Although it is clinically different from natural hirudin, it is resistant to The coagulation activity is low, the specificity of anticoagulant effect will be affected by the concentration of recombinant hirudin, and the anticoagulant effect is correspondingly high with high purity. Therefore, there is a great demand for natural hirudin clinically.
综上所述,现有技术存在的问题是:目前获取水蛭素的方法存在水蛭素产量极小,耗费成本较高,抗凝活性低的缺点。To sum up, the problems existing in the prior art are: the current method for obtaining hirudin has the disadvantages of extremely small hirudin yield, high cost and low anticoagulant activity.
发明内容Contents of the invention
针对现有技术存在的问题,本发明提供了一种日本医蛭唾液腺细胞的原代培养方法。Aiming at the problems existing in the prior art, the present invention provides a method for primary culture of Japanese leech salivary gland cells.
本发明是这样实现的,一种日本医蛭唾液腺细胞的原代培养方法,所述日本医蛭唾液腺细胞的原代培养方法包括将剪碎后的组织块接种于25cm2的细胞封闭培养瓶中,加入5mLSFX-INSCET昆虫细胞培养基,置于生化培养箱中29℃静止培养。The present invention is achieved in this way, a primary culture method of Japanese Hirudo salivary gland cells, the primary culture method of the Japanese Hirudo salivary gland cells comprises inoculating the shredded tissue pieces in a 25cm closed cell culture flask , add 5 mL of SFX-INSCET insect cell culture medium, and place in a biochemical incubator for static culture at 29°C.
进一步,所述接种之前需要:Further, before the inoculation:
步骤一,用水去除日本医蛭身体表面的粘稠状分泌物。清除干净之后,先放于0.3%高锰酸钾溶液中浸泡,再放入酒精溶液中浸泡,对日本医蛭进行消毒处理;Step 1, use water to remove the sticky secretions on the body surface of Japanese medical leeches. After cleaning up, soak in 0.3% potassium permanganate solution first, and then soak in alcohol solution to disinfect Japanese medical leeches;
步骤二,在超净工作台内,将经过体表灭菌的日本医蛭转移到装有PBS缓冲液的一次性无菌培养皿中,PBS缓冲液浸没日本医蛭,用经过高温高压灭菌处理的手术剪刀和镊子取下日本医蛭的前端头部;Step 2, in the ultra-clean workbench, transfer the Japanese medical leech sterilized on the body surface to a disposable sterile petri dish filled with PBS buffer, immerse the Japanese medical leech in the PBS buffer, and use high temperature and high pressure sterilized Handle the surgical scissors and tweezers to remove the front head of the Japanese medical leech;
步骤三,将头部转移到另一个装有PBS缓冲液的一次性无菌培养皿内,PBS缓冲液将其浸没,将日本医蛭的前端头部沿着口咽中部剪开,去除咽壁内表皮和外部皮肤,并用PBS漂洗;Step 3, transfer the head to another disposable sterile petri dish filled with PBS buffer, submerge it in PBS buffer, cut the front head of Japanese medical leeches along the middle of the oropharynx, and remove the pharyngeal wall Inner epidermis and outer skin, rinsed with PBS;
步骤四,将唾液腺置于酒精溶液中浸泡后,迅速将其转移至三个各装有PBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的器皿中各浸泡,并在第三个装有PBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的培养皿中,将其剪成组织块。Step 4, after soaking the salivary glands in the alcohol solution, quickly transfer them to three vessels each equipped with PBS buffer solution (containing 800 U/mL of penicillin/streptomycin/amphotericin mixed solution) for soaking, And in the third petri dish filled with PBS buffer solution (containing 800 U/mL penicillin/streptomycin/amphotericin mixed solution), cut it into tissue pieces.
进一步,所述步骤一中先放于0.3%高锰酸钾溶液中浸泡10min,再放入10%酒精溶液中浸泡10min,对日本医蛭进行消毒处理。Further, in the first step, soak in 0.3% potassium permanganate solution for 10 minutes, and then soak in 10% alcohol solution for 10 minutes to disinfect the leeches.
进一步,所述步骤四中将唾液腺置于75%酒精溶液中浸泡5-7S后,迅速将其转移至三个各装有1mLPBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的器皿中各浸泡5min。Further, after the salivary gland is placed in 75% ethanol solution and soaked for 5-7S in the described step 4, it is transferred to three each containing 1mL PBS buffer (containing 800U/mL of penicillin/streptomycin/amphotericin) Soak in each vessel for 5 minutes.
进一步,所述步骤四中剪成0.5mm3-1mm3大小的组织块。Further, in step 4, cut into tissue pieces with a size of 0.5 mm 3 -1 mm 3 .
本发明的另一目的在于提供一种利用所述日本医蛭唾液腺细胞的原代培养方法培养的日本医蛭。Another object of the present invention is to provide a Japanese leech cultured by using the primary culture method of the Japanese leech salivary gland cells.
本发明的优点及积极效果为:进行日本医蛭唾液腺细胞原代培养方法、培养基种类、抗生素种类和浓度等的选择筛选试验,建立日本医蛭原代细胞培养体系,实现医学蛭类唾液腺细胞的原代培养,以进一步实现传代培养。若日本医蛭唾液腺细胞体外培养能够实现,并且能够达到传代培养,天然水蛭素获取方式——从体外培养的日本医蛭唾液腺细胞中直接提取分离,始终维持较高水平的抗凝活性,并且大大提高天然水蛭素的产量,其产量明显高于直接从医蛭的唾液腺部位分离提取天然水蛭素以及用精氨酸等刺激医蛭使其分泌唾液腺分泌再收集唾液的现有方法。极少量的野生日本医蛭唾液腺细胞进行体外细胞培养后就能得到大量的唾液腺细胞,分离提取出大量天然水蛭素,有利于野生日本医蛭种群的保护,达到既深度开发利用又大力保护动物种质资源的目标。采用本发明对日本医蛭唾液腺细胞进行了原代培养,取得了较好的培养效果。The advantages and positive effects of the present invention are: to carry out the selection and screening test of the primary culture method of Japanese medical leech salivary gland cells, the type of medium, the type and concentration of antibiotics, etc., to establish the Japanese medical leech primary cell culture system, and to realize the medical leech salivary gland cells Primary culture for further subculture. If the in vitro culture of Hirudo salivary gland cells can be realized, and can be subcultured, the way to obtain natural hirudin - directly extracting and separating from Hirudo salivary gland cells cultured in vitro, will always maintain a high level of anticoagulant activity, and greatly Improve the output of natural hirudin, which is significantly higher than the existing methods of directly separating and extracting natural hirudin from the salivary glands of leeches and stimulating the leeches with arginine to secrete their salivary glands and then collecting saliva. A very small amount of wild Japanese leech salivary gland cells can be cultured in vitro to obtain a large number of salivary gland cells, and a large amount of natural hirudin can be isolated and extracted, which is conducive to the protection of wild Japanese leech populations, achieving both deep development and utilization and vigorous protection of animal species quality resource goals. The primary culture of Japanese hirudo salivary gland cells is carried out by adopting the invention, and better culture effect is obtained.
本发明快速、有效、重复性强,是对蛭类细胞培养的完善,为蛭类细胞原代培养的研究提供可靠的试验数据与基础。The invention is fast, effective and highly reproducible, perfects the culture of leech cells, and provides reliable test data and basis for the research on the primary culture of leech cells.
附图说明Description of drawings
图1是本发明实施例提供的日本医蛭唾液腺细胞的原代培养方法流程图。Fig. 1 is a flow chart of the primary culture method of Japanese hirudo salivary gland cells provided by the embodiment of the present invention.
具体实施方式detailed description
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
下面结合附图对本发明的应用原理作详细的描述。The application principle of the present invention will be described in detail below in conjunction with the accompanying drawings.
本发明从RPMI1640培养基、SFX-INSCET昆虫细胞培养基、M199培养基这3种培养基中筛选出最合适的培养基SFX-INSCET昆虫细胞培养基;从卡那霉素、新霉素、链霉素、硫酸庆大霉素、青霉素/链霉素/两性霉素B混合溶液、氨苄青霉素6种抗生素中筛选出最适合的抗生素青霉素/链霉素/两性霉素B混合溶液;对青霉素/链霉素/两性霉素B进行浓度梯度试验,筛选出最适合的浓度800U/mL;从而初步筛选出最适合日本医蛭细胞原代培养的培养体系。The present invention selects the most suitable culture medium SFX-INSCET insect cell culture medium from RPMI1640 culture medium, SFX-INSCET insect cell culture medium and M199 culture medium; Ampicillin, gentamicin sulfate, penicillin/streptomycin/amphotericin B mixed solution, and ampicillin were selected to select the most suitable antibiotic penicillin/streptomycin/amphotericin B mixed solution; Streptomycin/amphotericin B concentration gradient test was carried out, and the most suitable concentration of 800U/mL was screened out; thus the culture system most suitable for the primary culture of Japanese medical leech cells was preliminarily screened out.
如图1所示,本发明实施例提供的日本医蛭唾液腺细胞的原代培养方法包括以下步骤:As shown in Figure 1, the primary culture method of Japanese medicine leech salivary gland cells provided by the embodiment of the present invention comprises the following steps:
S101:用水去除日本医蛭身体表面的粘稠状分泌物。清除干净之后,先放于0.3%高锰酸钾溶液中浸泡10min,再放入10%酒精溶液中浸泡10min,对日本医蛭进行消毒处理;S101: Remove the viscous secretion on the body surface of Japanese medical leech with water. After cleaning up, soak in 0.3% potassium permanganate solution for 10 minutes, and then soak in 10% alcohol solution for 10 minutes to disinfect Japanese medical leeches;
S102:在超净工作台内,将经过体表灭菌的日本医蛭转移到装有PBS缓冲液的一次性无菌培养皿中,PBS缓冲液浸没日本医蛭,用经过高温高压灭菌处理的手术剪刀和镊子取下日本医蛭的前端头部;S102: In the ultra-clean workbench, transfer the Japanese leeches that have been sterilized on the body surface to a disposable sterile petri dish filled with PBS buffer. Use surgical scissors and tweezers to remove the front head of the Japanese medical leech;
S103:将头部转移到另一个装有PBS缓冲液的一次性无菌培养皿内,PBS缓冲液将其浸没,将日本医蛭的前端头部沿着口咽中部剪开,去除咽壁内表皮和外部皮肤,并用PBS漂洗;S103: Transfer the head to another disposable sterile petri dish filled with PBS buffer, submerge it in PBS buffer, cut the front head of Japanese medical leeches along the middle of the oropharynx, and remove the pharyngeal wall Epidermis and outer skin, rinsed with PBS;
S104:将唾液腺置于75%酒精溶液中浸泡5-7S后,迅速将其转移至三个各装有1mLPBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的器皿中各浸泡5min,并在第三个装有PBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的培养皿中,将其剪成0.5mm3-1mm3大小左右的组织块;S104: After soaking the salivary glands in 75% alcohol solution for 5-7S, quickly transfer them to three vessels each containing 1mL of PBS buffer solution (containing 800U/mL penicillin/streptomycin/amphotericin mixed solution) Soak in each of them for 5 minutes, and cut them into about 0.5mm 3 -1mm 3 size in the third Petri dish filled with PBS buffer solution (containing 800U/mL penicillin/streptomycin/amphotericin mixed solution) organization block;
S105:将剪碎后的组织块接种于25cm2的细胞封闭培养瓶中,加入SFX-INSCET昆虫细胞培养液,置于生化培养箱中29℃静止培养。S105: Inoculate the shredded tissue pieces into a 25 cm 2 closed cell culture flask, add SFX-INSCET insect cell culture medium, and place in a biochemical incubator for static culture at 29°C.
下面结合试验对本发明的应用效果作详细的描述。The application effects of the present invention will be described in detail below in conjunction with experiments.
试验具体的步骤如下:The specific steps of the test are as follows:
步骤一,用水去除日本医蛭身体表面的粘稠状分泌物。清除干净之后,先放于0.3%高锰酸钾溶液中浸泡10min,再放入10%酒精溶液中浸泡10min,对日本医蛭进行消毒处理;Step 1, use water to remove the sticky secretions on the body surface of Japanese medical leeches. After cleaning up, soak in 0.3% potassium permanganate solution for 10 minutes, and then soak in 10% alcohol solution for 10 minutes to disinfect Japanese medical leeches;
步骤二,在超净工作台内,将经过体表灭菌的日本医蛭转移到装有PBS缓冲液的一次性无菌培养皿中,PBS缓冲液浸没日本医蛭,用经过高温高压灭菌处理的手术剪刀和镊子取下日本医蛭的前端头部;Step 2, in the ultra-clean workbench, transfer the Japanese medical leech sterilized on the body surface to a disposable sterile petri dish filled with PBS buffer, immerse the Japanese medical leech in the PBS buffer, and use high temperature and high pressure sterilized Handle the surgical scissors and tweezers to remove the front head of the Japanese medical leech;
步骤三,将头部转移到另一个装有PBS缓冲液的一次性无菌培养皿内,PBS缓冲液将其浸没,将日本医蛭的前端头部沿着口咽中部剪开,去除咽壁内表皮和外部皮肤,并用PBS漂洗;Step 3, transfer the head to another disposable sterile petri dish filled with PBS buffer, submerge it in PBS buffer, cut the front head of Japanese medical leeches along the middle of the oropharynx, and remove the pharyngeal wall Inner epidermis and outer skin, rinsed with PBS;
步骤四,将唾液腺置于75%酒精溶液中浸泡5-7S后,迅速将其转移至三个各装有1mLPBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的器皿中各浸泡5min,并在第三个装有PBS缓冲液(含800U/mL的青霉素/链霉素/两性霉素混合溶液)的培养皿中,将其剪成0.5mm3-1mm3大小左右的组织块;Step 4, after soaking the salivary glands in 75% ethanol solution for 5-7S, quickly transfer them to three chambers each equipped with 1mL PBS buffer solution (containing 800U/mL penicillin/streptomycin/amphotericin mixed solution) Soak in each vessel for 5 minutes, and cut it into 0.5mm 3 -1mm 3 size in the third Petri dish filled with PBS buffer solution (containing 800U/mL penicillin/streptomycin/amphotericin mixed solution) left and right tissue blocks;
步骤五,原代培养培养基种类的筛选:将剪碎后的组织块接种于25cm2的细胞封闭培养瓶中,分三组,分别加入不同种类的培养基(培养基体积5mL),置于生化培养箱中29℃静止培养,7d后更换一半的培养液,并添加20%的灭活标准胎牛血清;结果在RPMI1640培养基中进行的原代细胞培养,接种培养第2天,肉眼观察到组织块多贴附于壁底,在显微镜下可以看到剪碎的组织块大小不一,形态多样,边缘呈现为较为明亮的亮带,培养液澄清没有杂质;接种培养第3-4天,肉眼观察到组织块贴附于壁底,培养液澄清,显微镜下观察到培养液中有少量黑色杂质;接种培养第5天,肉眼观察培养液浑浊,白色透明培养基略微变黄,污染物呈点状分布,倒置显微镜下观察到大量黑色细沙状杂质污染,细胞无生长迹象。在M199培养基中进行的原代细胞培养,接种培养第2-3天,肉眼观察组织块一半未贴壁,培养液澄清,倒置显微镜下观察到组织大小不一,形态多样,边缘呈现为较为明亮的亮带,培养液没有杂质;接种培养4-5天,大半组织块仍未贴壁,倒置显微镜下观察培养液澄清,细胞无生长迹象;接种培养第6-7天左右,培养基颜色变淡浑浊,肉眼观察到培养液中浮起一层白色的网纱状的污染物。在SFX-INSCET昆虫细胞培养基中进行原代细胞培养,接种培养第2-3天,肉眼观察到组织块多贴附于壁底,倒置显微镜下观察到组织大小不一,形态多样,边缘呈现为较为明亮的亮带,接种培养第3-4天,倒置显微镜下观察培养液依旧澄清,细胞暂无生长迹象;接种培养第5-6天,从组织块周缘游离出少量细胞,细胞形态为圆形,透明。Step 5, screening of the type of primary culture medium: inoculate the shredded tissue pieces into 25 cm 2 closed cell culture flasks, divide them into three groups, add different types of culture medium (medium volume 5 mL), place in Static culture in a biochemical incubator at 29°C, replace half of the culture medium after 7 days, and add 20% inactivated standard fetal bovine serum; results Primary cell culture in RPMI1640 medium, on the second day of inoculation, visual observation Most of the tissue blocks are attached to the bottom of the wall. Under the microscope, it can be seen that the shredded tissue blocks are of different sizes and shapes, and the edges appear as brighter bright bands. The culture medium is clear and free of impurities; the 3-4 days of inoculation and culture , it was observed with the naked eye that the tissue block was attached to the bottom of the wall, the culture medium was clear, and a small amount of black impurities were observed in the culture medium under a microscope; on the 5th day of inoculation culture, the culture medium was observed to be turbid with the naked eye, the white transparent medium turned yellow slightly, and pollutants Distributed in dots, a large amount of black fine sand-like impurities were observed under an inverted microscope, and the cells showed no signs of growth. The primary cell culture was carried out in M199 medium, on the 2nd to 3rd day of inoculation culture, half of the tissue block was not adhered to the wall, and the culture medium was clear. Under the inverted microscope, it was observed that the tissue size was different, the shape was various, and the edge appeared relatively Bright bright band, no impurities in the culture medium; 4-5 days after inoculation and culture, most of the tissue pieces are still not attached to the wall, the culture medium is clear under an inverted microscope, and the cells have no signs of growth; about 6-7 days after inoculation and culture, the color of the culture medium It became light and turbid, and a layer of white gauze-like pollutants floated in the culture solution with the naked eye. The primary cell culture was carried out in SFX-INSCET insect cell culture medium. On the 2nd to 3rd day of inoculation culture, it was observed with the naked eye that most of the tissue pieces were attached to the bottom of the wall. Under an inverted microscope, it was observed that the tissue size was different, the shape was various, and the edges appeared. It is a relatively bright bright band. On the 3rd to 4th day of inoculation and culture, the culture medium is still clear under an inverted microscope, and the cells have no signs of growth; on the 5th to 6th day of inoculation and culture, a small amount of cells are free from the periphery of the tissue block, and the cell shape is Round and transparent.
步骤六,原代培养抗生素种类的筛选:将剪碎后的组织块接种于25cm2的细胞封闭培养瓶中,加入步骤S105中最优的培养基后,分成六组,分别加入不同种类相同浓度(200U/mL)的抗生素/PBS缓冲液的混合溶液,置于生化培养箱中29℃静止培养;结果比较在同一种培养基(即SFX-INSCET昆虫细胞培养基)中经过同一浓度200U/mL不同抗生素种类的处理后的原代细胞生长存活及污染状态,发现在经过青霉素/链霉素/两性霉素B混合溶液浸泡处理过后的组织块原代培养时存活时间最长,保持培养液不被污染的时间也最长。Step 6, Screening of primary cultured antibiotics: Inoculate the shredded tissue pieces in a 25cm 2 closed cell culture flask, add the optimal medium in step S105, divide into six groups, add different kinds of the same concentration respectively (200U/mL) mixed solution of antibiotic/PBS buffer, placed in a biochemical incubator at 29°C for static culture; the results were compared in the same medium (ie SFX-INSCET insect cell culture medium) after the same concentration of 200U/mL The growth, survival and contamination status of primary cells treated with different types of antibiotics. It was found that the survival time of the tissue pieces soaked in the penicillin/streptomycin/amphotericin B mixed solution was the longest during the primary culture, and the culture medium was kept free of contamination. It also takes the longest time to be polluted.
步骤七,原代培养抗生素浓度的筛选:将剪碎后的组织块接种于25cm2的细胞封闭培养瓶中,加入步骤S105中最优的培养基后,分成六组,分别加入不用浓度、步骤S106中最优的抗生素,置于生化培养箱中29℃静止培养;结果比较在同一种培养基中经过同一种抗生素溶液(即“三抗”溶液)浸泡处理但是抗生素浓度不同的原代细胞生长存活及污染状态,发现在经过抗生素浓度为800U/mL(即抗生素:PBS缓冲液=800U:1mL)的浓度下,细胞污染状态最小,细胞存活时间最长,并观察到有新细胞生长的情况。Step 7, screening of antibiotic concentration in primary culture : Inoculate the shredded tissue pieces in a 25cm closed cell culture flask, add the optimal medium in step S105, divide into six groups, add different concentrations, step The best antibiotic in S106 was cultured statically in a biochemical incubator at 29°C; the results were compared to the growth of primary cells soaked in the same antibiotic solution (ie "three-antibody" solution) but with different concentrations of antibiotics in the same medium Survival and pollution state, it was found that after the antibiotic concentration was 800U/mL (ie antibiotic: PBS buffer = 800U: 1mL), the cell contamination state was the smallest, the cell survival time was the longest, and new cell growth was observed .
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements and improvements made within the spirit and principles of the present invention should be included in the protection of the present invention. within range.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710354224.6A CN107129962B (en) | 2017-05-18 | 2017-05-18 | A kind of primary culture method of Hirudo japonica salivary gland cell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710354224.6A CN107129962B (en) | 2017-05-18 | 2017-05-18 | A kind of primary culture method of Hirudo japonica salivary gland cell |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107129962A true CN107129962A (en) | 2017-09-05 |
CN107129962B CN107129962B (en) | 2019-03-05 |
Family
ID=59731970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710354224.6A Active CN107129962B (en) | 2017-05-18 | 2017-05-18 | A kind of primary culture method of Hirudo japonica salivary gland cell |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107129962B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108265021A (en) * | 2018-03-29 | 2018-07-10 | 苏州至汇生物科技有限公司 | A kind of leech cell injuring model base and its cultural method |
CN111979174A (en) * | 2020-08-26 | 2020-11-24 | 中国计量大学 | Method for separating hirudo nipponica salivary gland cells |
CN114657120A (en) * | 2022-04-20 | 2022-06-24 | 中国计量大学 | Method for obtaining hirudo nipponica salivary gland stem cell mass through enzymolysis and application |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103820381A (en) * | 2014-01-23 | 2014-05-28 | 中国计量学院 | Primary culture method for chilo suppressalis cells |
CN104611288A (en) * | 2014-12-30 | 2015-05-13 | 中国计量学院 | Primary culture method of ampullaria gigas heart tissue cell |
CN105861416A (en) * | 2016-06-06 | 2016-08-17 | 西北民族大学 | Serum-free medium for culturing insect cells in full suspension mode and preparation method and application thereof |
CN105861417A (en) * | 2016-06-06 | 2016-08-17 | 中国计量大学 | Establishment method for pomacea canaliculata ovary cell line |
US9433648B2 (en) * | 2012-09-17 | 2016-09-06 | Biopep Solutions, Inc. | Treating renal cancer with a whole, leech saliva extract |
-
2017
- 2017-05-18 CN CN201710354224.6A patent/CN107129962B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9433648B2 (en) * | 2012-09-17 | 2016-09-06 | Biopep Solutions, Inc. | Treating renal cancer with a whole, leech saliva extract |
CN103820381A (en) * | 2014-01-23 | 2014-05-28 | 中国计量学院 | Primary culture method for chilo suppressalis cells |
CN104611288A (en) * | 2014-12-30 | 2015-05-13 | 中国计量学院 | Primary culture method of ampullaria gigas heart tissue cell |
CN105861416A (en) * | 2016-06-06 | 2016-08-17 | 西北民族大学 | Serum-free medium for culturing insect cells in full suspension mode and preparation method and application thereof |
CN105861417A (en) * | 2016-06-06 | 2016-08-17 | 中国计量大学 | Establishment method for pomacea canaliculata ovary cell line |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108265021A (en) * | 2018-03-29 | 2018-07-10 | 苏州至汇生物科技有限公司 | A kind of leech cell injuring model base and its cultural method |
CN108265021B (en) * | 2018-03-29 | 2021-08-27 | 苏州至汇生物科技有限公司 | Leech cell in-vitro culture medium and culture method thereof |
CN111979174A (en) * | 2020-08-26 | 2020-11-24 | 中国计量大学 | Method for separating hirudo nipponica salivary gland cells |
CN114657120A (en) * | 2022-04-20 | 2022-06-24 | 中国计量大学 | Method for obtaining hirudo nipponica salivary gland stem cell mass through enzymolysis and application |
Also Published As
Publication number | Publication date |
---|---|
CN107129962B (en) | 2019-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104762260A (en) | Preparation method and application of adipose-derived mesenchymal stem cells and preparation thereof | |
CN108192862A (en) | A kind of preparation method of pilose antler stem cell, pilose antler stem cell and its application | |
CN107129962A (en) | A kind of primary culture method of Hirudo japonica salivary gland cell | |
CN104206359A (en) | Method using composite bait of microalgae and other microorganisms to culture artemia | |
Biggs et al. | Egg capsule sheath of Loligo opalescens Berry: structure and association with bacteria | |
CN102492623B (en) | Method for preparing and culturing culture medium for supravital culture of seawater scuticociliatida ciliates | |
CN103820381B (en) | A kind of primary culture method of striped rice borer cell | |
CN108048327A (en) | A kind of new method for efficiently separating diatom | |
CN104531608A (en) | Anguilla anguilla liver cell line and construction method and application thereof | |
CN109486680A (en) | Method for separating, culturing and storing microsporidian strain (strain) of tussah | |
CN102972355A (en) | Method for breeding, culturing and storing plant nematodes by using sweet potato calluses | |
CN107858322B (en) | A method for establishing a hippocampal primary cell culture system | |
CN108265021B (en) | Leech cell in-vitro culture medium and culture method thereof | |
KR20020086216A (en) | Production method of biotechnological rice, cultured medicinal mushroom's mycellium | |
CN112931304B (en) | Method for improving attachment of coral larvae | |
CN116814525A (en) | A medium for culturing Dongfeng snail embryos and a method for cultivating Dongfeng snail embryos outside the capsule | |
CN103820382A (en) | Construction method for fat body cell line of chilo suppressalis larva | |
CN105861417A (en) | Establishment method for pomacea canaliculata ovary cell line | |
CN101486991B (en) | Method for propagating Tortula muralis protonema by cell engineering cultivation | |
CN104611288A (en) | Primary culture method of ampullaria gigas heart tissue cell | |
CN104920066A (en) | Method for Improving Cordyceps Sinensis Host Infection Rate | |
CN114807012B (en) | Method for separating, culturing and establishing stress model of takifugu obscurus intestinal epithelial cells | |
CN110872564A (en) | A kind of wild fungus tissue separation method | |
CN103820380A (en) | Primary culture method for chilo suppressalis blood lymphocytes | |
Sinmuk et al. | Aphanomyces infection in juvenile soft-shelled turtle, Pelodiscus sinensis, imported from Singapore |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170905 Assignee: Xinchang China Metrology University Enterprise Innovation Research Institute Co.,Ltd. Assignor: China Jiliang University Contract record no.: X2021330000071 Denomination of invention: A primary culture method of salivary gland cells of Japanese medical leech Granted publication date: 20190305 License type: Common License Record date: 20210816 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Xinchang China Metrology University Enterprise Innovation Research Institute Co.,Ltd. Assignor: China Jiliang University Contract record no.: X2021330000071 Date of cancellation: 20211231 |
|
EC01 | Cancellation of recordation of patent licensing contract |